Endothelial recovery: the next target in restenosis prevention.
Losordo
Douglas W
DW
Isner
Jeffrey M
JM
Diaz-Sandoval
Larry J
LJ
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002455:Cell Division / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D023903:Coronary Restenosis / Q000517:prevention & control*; D016228:Endothelial Growth Factors / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D005240:Feasibility Studies; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics; D008222:Lymphokines / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000503:physiopathology; D010865:Pilot Projects; D015607:Stents / Q000009:adverse effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000970:Antineoplastic Agents; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors